MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Digital Health Interventions for Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    RW. Liu, SR. Zhang, YF. Chen, HF. Shang (Chengdu, China)

    Objective: To assess the effectiveness of digital health interventions (DHIs) in patients with Parkinson's disease (PD) and report on their reach, uptake, and feasibility. Background:…
  • 2025 International Congress

    Enhancing Safety and Quality of Care for Parkinson’s Disease Patients Hospitalized at a Large Academic Medical Center

    C. Kim, C. Malatt, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)

    Objective: To implement measures to improve quality of care in Parkinson's disease (PD) patients who are hospitalized at a large academic hospital with the goal…
  • 2025 International Congress

    Parkinson’s Exercise Guidelines: From Outdated to Updated

    M. Rafferty, L. Hoffman, L. Krasucki, D. Corcos (Chicago, USA)

    Objective: To align the 2021 Parkinson’s Exercise Guidelines with current evidence and stakeholder feedback. Background: In 2021, the Parkinson’s Foundation, in partnership with the American…
  • 2025 International Congress

    The Role of Research and Genetics Educational Events in Parkinson’s Research: Overcoming Barriers in the Hispanic Community

    A. Coral-Zambrano, M. Rodriguez Violante, J. Orozco Velez, M. Inca Martinez, I. Mata, P. Hodges, R. de León (Miami, USA)

    Objective: To assess the impact of educational events that emphasize research and genetics as well as culturally adapted recruitment strategies on increasing Hispanic participation in…
  • 2025 International Congress

    Clinical Characteristics and Biomarkers in Parkinson’s Disease Patients with Body-first versus Brain-first Subtypes in Parkinson’s Disease

    S. Li, Y. Tang, J. Wang (Shanghai, China)

    Objective: To investigate clinical characteristics, disease progression, potential plasma and imaging biomarkers of body-first and brain-first Parkinson’s disease (PD) subtypes. Background: PD can be classified…
  • 2025 International Congress

    Contribution of β-band functional connectivity to the α-synuclein propagation in early-stage Parkinson’s Disease: insights from the analysis of brain network properties

    M. Conti, A. Guerra, V. Ferrari, V. D'Onofrio, G. Sancesario, M. Pierantozzi, NB. Mercuri, A. Antonini, T. Schirinzi, A. Stefani (Rome, Italy)

    Objective: To investigate the relationship between CSF α-synuclein levels and EEG-based network properties, aiming to clarify their role in PD pathophysiology. Background: Parkinson’s disease (PD)…
  • 2025 International Congress

    Key components for safer mobility behaviour assessment and intervention for people with Parkinson’s disease: A modified Delphi study

    D. Cheung, S. Paul, L. Mackenzie, J. Wesson, N. Allen (Camperdown, Australia)

    Objective: To develop a consensus-based summary of key components that people with lived experience, clinicians and researchers find important to include in an assessment tool…
  • 2025 International Congress

    Prospective observational study on the effects of physical exercise and lifestyle modifications in patients with Parkinson’s disease

    T. Lata (Mumbai, India)

    Objective: This study aimed to assess the effectiveness of physical activity, which includes all movements that increase energy expenditure, in conjunction with exercise, characterized as…
  • 2025 International Congress

    Nutritional Parameter Changes in Parkinson’s Disease Patients Receiving Continuous Subcutaneous Infusion of Foslevodopa-Foscarbidopa

    M. Barichella, MC. Macchione, G. Lazzeri, E. Cereda, I. Ioannis, G. Pezzoli (Milano, Italy)

    Objective: This study aims to assess changes in nutritional parameters in patients with Parkinson’s disease (PD) undergoing continuous subcutaneous infusion (CSCI) of foslevodopa-foscarbidopa. Background: Device-aided…
  • 2025 International Congress

    Clinical Efficacy, Cost Effectiveness, and Caregiver Satisfaction of the Application of Parkinson’s KinetiGraph (PKG) in Clinical Practice versus Standard Care – a 12-month Longitudinal Analysis Part of the EmPARK-PKG Project

    V. Metta, M. Qamar, H. Benamer, T. Loney, G. Goyal, R. Dhamija, P. Kukle, R. Borgohain, R. Mridula, H. Hussain, A. Nalarakettil, R. Chaudhuri (London, United Kingdom)

    Objective: To evaluate the clinical efficacy, care giver satisfaction and cost-effectiveness in the clinical management of Parkinson's Disease (PD) compared to conventional care over 12…
  • « Previous Page
  • 1
  • …
  • 259
  • 260
  • 261
  • 262
  • 263
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley